EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Altered Gene Expression of IL-35 and IL-36α in the Skin of Patients with Atopic Dermatitis

Weronika Zysk iD, Krzysztof Sitko iD, Stefan Tukaj iD, Anna Zaryczańska iD, Magdalena Trzeciak iD

International Journal of Molecular Sciences · 2023

DOI: 10.3390/ijms25010404 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2023. Verfasst von Weronika Zysk und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, Venereology and Allergology, Medical University of Gdansk, 80-214 Gdansk, Poland. Hauptthemen laut MEDLINE: Biological Products, Dermatitis, Atopic. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Science Center, Polish National Science Centre (NCN).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

A comprehensive understanding of atopic dermatitis (AD) pathogenesis is desired, especially in the current era of novel biologics and small molecule drugs. In recent years, new cytokines have emerged that may play a significant role in the pathogenesis of AD. Using the tape stripping (TS) method, this study analyzed the gene expression of IL-35 and IL-36α in lesional and nonlesional AD skin compared with healthy skin and their association with the clinical features of AD among the Polish population. Ten AD patients and seven healthy individuals were enrolled. The lesional skin of the AD patients showed significantly higher expression levels of IL-35 compared to healthy skin (p = 0.0001). The expression level of IL-36α was significantly higher in lesional AD skin than in nonlesional AD skin (p = 0.0039) and healthy skin (p = 0.0045). There was a significant negative correlation between AD severity and the expression level of IL-35 in both lesional (R = −0.66, p = 0.048) and nonlesional skin (R = −0.9, p = 0.0016). In summary, both IL-35 and IL-36α appear to play a role in the pathogenesis of AD. Furthermore, it might be speculated that IL-35 and IL-36α may be potential candidates for disease biomarkers. However, further studies are needed to verify these assumptions and comprehensively elucidate their importance in the pathogenesis of AD.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Biological ProductsDermatitis, AtopicHumansGene ExpressionInterleukinsSkinInterleukin-12 Subunit p35Interleukin-1

Stichwörter der Autor:innen

atopic dermatitisbiomarkerskin immunologytape stripping

Substanzen

Biological ProductsInterleukinsIL12A protein, humanInterleukin-12 Subunit p35IL36A protein, humanInterleukin-1

Autor:innen und Institutionen

  • Department of Dermatology, Venereology and Allergology, Medical University of Gdansk, 80-214 Gdansk, Poland.
  • Department of Molecular Biology, Faculty of Biology, University of Gdansk, 80-308 Gdansk, Poland.

ORCID-Profile: Weronika Zysk, Krzysztof Sitko, Stefan Tukaj, Anna Zaryczańska, Magdalena Trzeciak

Förderung

  • National Science Center
  • Polish National Science Centre (NCN)

Zitieren

APA

Zysk, W., Sitko, K., Tukaj, S., Zaryczańska, A., & Trzeciak, M. (2023). Altered Gene Expression of IL-35 and IL-36α in the Skin of Patients with Atopic Dermatitis. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms25010404

Vancouver

Zysk W, Sitko K, Tukaj S, Zaryczańska A, Trzeciak M. Altered Gene Expression of IL-35 and IL-36α in the Skin of Patients with Atopic Dermatitis. International Journal of Molecular Sciences. 2023. doi:10.3390/ijms25010404

BibTeX
@article{Zysk2023,
  author = {Zysk, Weronika and Sitko, Krzysztof and Tukaj, Stefan and Zaryczańska, Anna and Trzeciak, Magdalena},
  title = {Altered Gene Expression of IL-35 and IL-36α in the Skin of Patients with Atopic Dermatitis},
  journal = {International Journal of Molecular Sciences},
  year = {2023},
  doi = {10.3390/ijms25010404}
}
Kostenlos starten →